Microbial cytoplasmic membrane lipids and associated inflammatory cascades

Microbial cytoplasmic membrane lipids and associated inflammatory cascades represent a complex interface between pathogen structural biology and host innate immunity. Microbial lipids, including phosphatidylglycerol, cardiolipin, and lipopolysaccharide (LPS), are essential for bacterial membrane integrity and serve as potent pathogen-associated molecular patterns (PAMPs) [1][2]. These molecules are recognized by host pattern recognition receptors (PRRs), such as Toll-like receptor 4 (TLR4) and TLR2, which initiate intracellular signaling cascades leading to the production of pro-inflammatory cytokines [3]. While this immune response is vital for controlling infection, its dysregulation can lead to systemic inflammatory response syndrome (SIRS), sepsis, and multi-organ failure [4]. Therapeutic strategies targeting this system include membrane-disrupting antibiotics like polymyxins and daptomycin, which directly compromise microbial viability [5]. Additionally, experimental therapies have focused on blocking the inflammatory cascade by antagonizing PRRs or neutralizing circulating microbial lipids to prevent septic shock [6].

Other names

Bacterial membrane lipidsMicrobial pathogen-associated molecular patterns (PAMPs)Endotoxin-mediated inflammatory signalingMicrobial lipid-induced inflammation

Drugs targeting this system act by binding to microbial membrane lipids to cause physical disruption and leakage (e.g., daptomycin, polymyxins) or by antagonizing host receptors that recognize these lipids to prevent the initiation of inflammatory signaling cascades (e.g., TLR4 antagonists).